Indication: Neuroblastoma

LEAHRN (Late Effects After High-Risk Neuroblastoma) Study

Sub-indication: Neuroblastoma

Study Type: Specimen Study

Principal Investigator: Kerry K. McGowan, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Children's Oncology Group (COG)

Learn more at ClinicalTrials.gov

Email for more information: NCRI-Cancer@NortonHealthcare.org

Search our entire site.